SEC Tracker
Get the app

Editas Medicine EDIT

Erick Lucera (Officer) plans to sell 45,000 EDIT shares, about $256,950

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: May 17, 2024
  2. Broker: ETrade Financial Corporation
  3. Shares acquired by: Restricted Stock Unit Vesting
  4. 10b5-1 plan adopted: May 12, 2023

All of Erick Lucera's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 22,337 shares at $5.61 on May 20, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Editas Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Merus MRUS
  2. Palvella Therapeutics PVLA public float $197M, Jun 30, 2025
  3. Esperion Therapeutics ESPR public float $198M, Jun 30, 2025
  4. Rezolute RZLT public float $204M, Dec 31, 2025
  5. Cardiff Oncology CRDF public float $205M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.